Clinical Trial Update: A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With Obesity [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of topiramate in obesity has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Topiramate (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Obesity | Phase 3 | Status: COMPLETED